Osaic Holdings
TARS icon

Osaic Holdings’s Tarsus Pharmaceuticals TARS Stock Holding History

Osaic Holdings’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.9K Sell
1,572
-38
-2% -$2.43K ﹤0.01% 4954
2026
Q1 		$113K Buy
1,610
+67
+4% +$4.68K ﹤0.01% 4589
2025
Q4 		$126K Sell
1,543
-1,035
-40% -$77.3K ﹤0.01% 4514
2025
Q3 		$151K Sell
2,578
-200
-7% -$9.85K ﹤0.01% 4451
2025
Q2 		$113K Buy
2,778
+2,462
+779% +$111K ﹤0.01% 4413
2025
Q1 		$16.2K Buy
316
+170
+116% +$8.4K ﹤0.01% 5501
2024
Q4 		$8.08K Sell
146
-59
-29% -$2.68K ﹤0.01% 5917
2024
Q3 		$6.74K Sell
205
-17
-8% -$478 ﹤0.01% 6061
2024
Q2 		$6.03K Hold
222
– – ﹤0.01% 6079
2024
Q1 		$8.07K Buy
222
+42
+23% +$1.24K ﹤0.01% 5868
2023
Q4 		$3.65K Hold
180
– – ﹤0.01% 6293
2023
Q3 		$3.2K Sell
180
-59
-25% -$1.04K ﹤0.01% 6445
2023
Q2 		$4.32K Sell
239
-330
-58% -$5.25K ﹤0.01% 6378
2023
Q1 		$7.15K Hold
569
– – ﹤0.01% 6165
2022
Q4 		$8.57K Buy
569
+369
+185% +$6.11K ﹤0.01% 6032
2022
Q3 		$3K Hold
200
– – ﹤0.01% 6667
2022
Q2 		$3K Hold
200
– – ﹤0.01% 6764
2022
Q1 		$3K Hold
200
– – ﹤0.01% 6773
2021
Q4 		$5K Hold
200
– – ﹤0.01% 6658
2021
Q3 		$4K Buy
+200
New +$4.95K ﹤0.01% 6656

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's TARS Position: Q2 2026 in Review

Osaic Holdings reduced its Tarsus Pharmaceuticals (TARS) stake by 2.4% in Q2 2026, selling an estimated $2.43K and leaving 1,572 shares worth $98.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4954.

Osaic Holdings first reported a position in TARS in Q3 2021 and has held it in 20 quarters since. The position peaked at $151K in Q3 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Osaic Holdings held 1,572 shares of Tarsus Pharmaceuticals worth $98.9K as of Q2 2026.
  • Osaic Holdings sold 38 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $2.43K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4954 holding.
  • Osaic Holdings first reported a position in Tarsus Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • Osaic Holdings's Tarsus Pharmaceuticals position peaked at $151K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.